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1. INTRODUCTION
1.1.  Systemic Arterial Hypertension  
and Cognitive Function
It is estimated that Systemic Arterial Hypertension (SAH) affects 
more than 40% of adults worldwide [1] and is strongly associated 
with coronary artery disease, stroke, and heart failure [2]. Blood 
Pressure (BP) rises with age; High BP (HBP) affects 50% of adults 
aged ≥60 years, and has a lifetime prevalence of 90% [3]. The World 
Health Organization estimates that suboptimal BP (>115 mmHg 
systolic BP) is responsible for 62% of cerebrovascular disease [4]. 
Numerous studies have demonstrated that SAH increases the risk 
of cognitive impairment, Alzheimer’s Diseases (AD) and vascular 
dementia [5–16], contributing to the increased burden of the dis-
ease worldwide, whose prevalence is achieving alarming figures 
[17]. Dementia in high-income countries ranks mainly between 
3rd and 6th place as a cause of disability adjusted life years over the 
last 25 years [18].
The Atherosclerosis Risk in Communities Cohort (ARIC) study 
[19] has followed 13.476 individuals for 20 years, trying to under-
stand the influence that increased BP, registered in mid-life (48–67 
years old), might have in the development of cognitive dysfunc-
tion in later stages of life. The investigators were able to show that 
subjects exposed to SAH and pre-hypertension in mid-life had a 
higher (6.5% and 4.8%, respectively) cognitive function in various 
domains using a complete neurocognitive assessment (especially 
executive dysfunction). In fact, the trajectories of cognitive func-
tion in individuals with SAH demonstrated faster decline in global 
cognition and several cognitive domains [20], including worse 
performance in the executive function and information processing 
speed [21].
Furthermore, SAH is associated with subtle neurocognitive defi-
cits [22,23] which may be potentiated by one’s lifestyle, like obesity 
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A B S T R AC T
Systemic Arterial Hypertension (SAH) is a chronic condition that requires clinical treatment and is associated with increased 
risk of cognitive impairment and dementia. Therefore, strategies with fewer side effects and less invasive procedures are required. 
Evidence supports that Physical Exercise (PE) has antihypertensive effects and has proven to be an efficient and complementary 
tool for managing hypertension, reducing cardiovascular disease risk factors, and improving cerebral perfusion in the majority of 
healthy populations. Much of this cardiovascular-protective effect of PE is probably due to pluripotent effects on the vasculature, 
including regulation of vascular tone, energy metabolism, microvascular recruitment, and endothelial function (reducing 
oxidative stress and preserving NO availability). These factors are speculated to work synergistically, thereby reducing systolic 
and diastolic blood pressure and are directly related to improved cerebrovascular function. However, few studies have specifically 
examined the potential positive effects of PE on the brain in hypertensive individuals. In this brief review, we discuss the potential 
effect of different PE modalities (aerobic, resistance, and combined) that may act as an effective preventive or therapeutic strategy 
for reducing blood pressure in hypertensives and, consequently, mitigate the association between hypertension, cognitive 
impairment and risk of dementia.
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[24], smoking [25], sedentary behavior [26], stress [27] and may 
further increase the risk of dementia [28]. Taken together, this 
background is associated with an increased chance SAH individ-
uals have for developing vascular dementia, especially those who 
have been exposed to this condition for years [29].
A more comprehensive understanding of modifiable dementia 
risk factors should be based on interventions that can potentially 
prevent or delay the onset of the condition, and the possible target 
periods for intervention would extend from prenatal period to old 
age [30]. The Lancet Commission on dementia concluded that up 
to 35% of all cases may be attributable to potentially modifiable risk 
factors including physical inactivity, SAH, obesity, diabetes, smok-
ing, hearing loss, education, depression and social isolation [31]. 
As such, there is strong, ongoing demand for evidence-based strat-
egies that prevent, delay, or reverse age-associated increases in BP 
and cognitive decline [32–38]. Indeed, the need for new approaches 
is expected to grow as the burden of age- and accelerated aging- 
associated cardiovascular dysfunction and disease continues to rise 
[39]. An alternative therapeutic approach to HBP [35–38,40], vas-
cular health [41–45] and cognitive dysfunction [29,46], is physical 
exercises [39].
Physical Exercises (PEs), in particular, has pluripotent effects on the 
vasculature, including regulation of the vascular tone [47], Cerebral 
Blood Flow (CBF) [48], endothelial function [42,49], microvascu-
lar recruitment [50], energy metabolism [51], vessel insulin actions 
[52], and antihypertensive effects [36–38,53], all important factors 
for brain health. PE might be an effective intervention to mitigate 
the association between SAH and cognitive impairment. In this 
brief review, we discuss the potential of PE to act as an effective 
preventive or therapeutic strategy for preventing or restoring SAH, 
and link it to cognition function and brain health. The focus will be 
primarily on studies in humans.
2.  PHYSICAL EXERCISE AS A MEDIATOR 
IN SYSTOLIC ARTERIAL HYPERTENSION
Guidelines [54–56] recommend that SAH individuals perform at 
least 30 min of moderate intensity Aerobic Exercise (AE) ≥3–5 
days a week (but preferably every day), supplemented by dynamic 
Resistance Training (RT). Cornelissen and Smart [57] showed 
that AE training [moderate to high intensity, <210 min/week or 
40–60% Hear Rate (HR) reserve] contributed to reduce Systolic BP 
(SBP) and Diastolic BP (DBP) (8.5 and 5.1 mmHg, respectively; 
p < 0.001 for both comparisons) in hypertensive subjects. Wen 
and Wang [58] have observed decreased SBP (by 7 mmHg) and 
DBP (by 5 mmHg) in essential hypertensive patients. The study 
conducted by Moriguchi et al. [59] found that AE training at 50% 
VO2max twice a week over a period of 3 months promoted benefits 
in Flow-Mediated Dilatation (FMD) from 5.2% (pre-training) to 
8.7% (post-training; p < 0.001) in hypertensive individuals. Also, 
there was a reduction in SBP (14.5 mmHg) and DBP (9.6 mmHg) 
in the study. Vigorous AE training intensities may be considered in 
patients with HBP. Molmen-Hansen et al. [60] observed that AE 
performed by hypertensive individuals for 12 weeks improved FMD 
(before: 6.5 ± 3.7 and after: 10.7 ± 5.0%; p < 0.001) only in the group 
that practiced AE in high intensities (alternating between 60–70% 
and 90–95% of HR reserve). Ashor et al. [61] showed significantly 
reduced Pulse Wave Velocity (PWV) in hypertension subgroups 
analyses −0.66 (−1.23 to −0.10 m/s; p < 0.02). A significantly 
higher reduction in PWV after AE intervention in participants 
with stiffer arteries (PWV > 8 m/s) was also shown.
Cornelissen et al. published a set of meta-analyses on the effects of 
RT on BP in 2005 [36], 2011 [38], and 2013 [37]. In the 2005 publi-
cation, data from nine Randomized Clinical Trials (RCTs) 110 were 
pooled, and the investigators concluded that RT reduced SBP (by 
3.2 mmHg and DBP at 3.5 mmHg). Subsequent meta-analysis (2011) 
showed that isometric RT (handgrip) may be more effective in reduc-
ing BP levels (SBP: 13.5 mmHg and DBP: 6.1 mmHg) than dynamic 
RT (SBP: 2.8 mmHg and DBP: 2.7 mmHg). In 2013, the meta-analysis 
confirmed the superiority of isometric RT in reducing SBP 
(10.9 mmHg) and DBP (6.2 mmHg); however, only four stud-
ies for isometric training were analysed [57]. Similar findings 
for the efficacy of isometric exercise were reported in another 
meta-analysis [62,63]. A reduction in SBP of 3.0 mmHg and 
DBP of 3.0 mmHg was observed. MacDonald et al. [63] con-
ducted a meta-analysis with 64 controlled studies (71 interven-
tions) to determine the efficacy of dynamic RT as a stand-alone 
antihypertensive therapy. Participants (N = 2344) were white 
(57%), middle-aged (47.2 ± 19.0 years), and overweight (26.8 ± 
3.4 kg/m2) adults with SAH (126.7 ± 10.3/76.8 ± 8.7 mmHg); 
15% were on antihypertensive medication. Overall, moderate- 
intensity dynamic RT [65–70% of One-Repetition Maximum 
(1RM)] was performed 2.8 ± 0.6 days/week for 14.4 ± 0.9 weeks 
and elicited small-to-moderate reductions in SBP (3.0 mmHg) and 
DBP (2.1 mmHg) compared with controls (p < 0.001). HBP reduc-
tions occurred among samples with higher resting SBP/DBP: ≈6/5 
mmHg for hypertension, ≈3/3 mmHg for prehypertension, and 
≈0/1 mmHg for normal BP (p < 0.023) [63]. On the other hand, 
study conducted by Moraes et al. [64] show that middle-aged, 
stage 1 hypertensive patients without antihypertensive medication 
(reaching 153 ± 6/93 ± 2 mmHg SBP/DBP after a 6-week medi-
cation washout period), submitted to a 12-week conventional RT 
program (3 sets of 12 repetitions at 60% 1 RM, 3 times a week on 
nonconsecutive days) reduced SBP (16 mmHg; p < 0.001), DBP 
(12 mmHg; p < 0.01) and mean BP (13 mmHg; p < 0.01) to prehy-
pertensive values. Moreover, the benefits of BP reduction achieved 
with RE training remained unchanged for up to 4 weeks without 
exercise. Similarly, in the study Beck et al. [65] observed reduc-
tion in SBP (9.6 mmHg) and DBP (8 mmHg), in young unmedi-
cated prehypertensive after 8 weeks dynamic RT protocol (2 sets of 
8–12 repetitions at 60% 1 RM, 3 times a week ) and improvement 
in FMD from 6.2% to 8.30%, concomitant with reduction in the 
Endothelin-1 level (ET-1). Thus suggesting the effectiveness of the 
RT in improving the endothelial artery function and oxidant/anti-
oxidant balance in young prehypertensive. Both studies demon-
strate the potential usefulness of conventional moderate-intensity 
(60% 1RM, ) RT in the treatment of stage 1 hypertensive patients.
The evidence discussed earlier suggests the antihypertensive effects 
of isolated AE training (5–8 mmHg) and dynamic RT training 
(≈2–3 mmHg) for the same population [35–38,63]. Thus, it would 
be logical to think that combined exercises (AE + RT) performed 
in a single session or within a couple of hours one from another, 
which is referred to as concurrent [66] exercise or combined 
aerobic and resistance exercise [67], could enhance the antihy-
pertensive effect. The Combined Training (CT) conferred the 
antihypertensive benefit to SAH individuals ≈15–9 mmHg [68] 
compared with prehypertension ≈2–7–4 mmHg [69], older men 
with SAH (12–24 mmHg) from BP at rest, respectively. Stewart 
et al. [70] reported average reductions of 5.3 and 3.7 mmHg for SBP 
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and DBP, respectively, in hypertensive older adults who completed 
a concurrent training protocol for 6 months. When the training 
frequency amounted to three weekly sessions, the training inten-
sity ranged from 50–80% of 1RM and 60–90% HRmax and train-
ing duration per session averaged 40–90 min. However, the aortic 
stiffness, indexed by aortofemoral PWV, was unchanged [70]. 
Son et  al. [71] showed that 12 weeks of combined moderate 
(60–70% HR reserve) aerobic and resistance exercise training is a 
useful exercise modality for improving brachial-ankle PWV (Δ1.11 
± 0.63 m/s, p < 0.05), both SBP (Δ13.5 ± 1.58 mmHg, p < 0.05) and 
DBP (Δ11 ± 1.34 mmHg, p < 0.05), and functional capacity (Δ4.4 ± 
3.89, p < 0.05) in postmenopausal women with stage 1 hypertension.
3.  PHYSICAL EXERCISE, COGNITION 
FUNCTION, ARTERIAL FUNCTION  
AND BRAIN HEALTH
Lifestyle habits, including PE, associated with 35% reduction in 
CVD risk factors and mortality [72] are promising approaches 
for the prevention of neurocognitive decline [33,73], and physically 
active (PA) individuals are less likely to develop dementia [74,75]. 
Evidence suggests that AE improves brain structural integrity – 
brain volume [76], neurocognitive performance [34] associated 
with increased attention, executive function, and memory [77]. 
In addition, PE promotes several molecular and structural adap-
tations in different neurotrophils in the human brain such as Brain 
Derived Neurotrophic Factor (BDNF) [78,79], which mediates 
neuronal survival, plasticity, and synapse reinforcement [79]. It 
has been observed that PE training is associated with higher CBF, 
higher metabolic activity in the hippocampus, and better memory 
compared with the control group that did not exercise [80,81]. 
Also, PE is associated with increased length, complexity, and den-
sity of some types of neuron dendrites [82], and greater integrity of 
the Blood–Brain Barrier (BBB) [83]. Taking together, it is suggested 
that PE promotes several molecular and structural adaptations that 
can improve cognitive functioning [84,85].
Additionally, the cause and effect relationship between PE and 
cerebral perfusion [86] may be attributed to hemodynamics effects, 
including BP [35–38,63], endothelial function [41,49,50,65,87,88] 
and arterial remodeling [42,43,61,89–92]. PE provides benefits not 
only to the vascular beds that are involved during the session, but also 
to those in non-working sites or limbs [93,94]. This phenomenon 
could be explained by the increased shear stimuli in non-working 
limbs during an exercise bout [95]. The proposed mechanisms 
through which PE may prevent the development and treatment 
of SAH are presented in Table 1. It is speculated that these factors 
work synergistically, thereby reducing systolic and diastolic BP and 
improvement in vascular function. It is plausible that PE training 
may contribute to improved CBF in hypertensive individuals.
Summary of mechanisms through which PE promotes vascular 
adaptation, adapted from Green et al. [96] and Diaz et al. [97].
4. PERSPECTIVES AND CONCLUSION
Therefore, despite the lack of direct evidence showing a relation-
ship between exercise and cognitive function in hypertensive 
Table 1 | Proposed mechanisms through which PE may treat and prevent 
the development of hypertension
Reduction Improvement
Vascular resistance Endothelial function
Arterial stiffness Arterial compliance
Intima-media thickness Arterial lumen diameter
Renin-angiotensin system activity Angiogenesis and arteriogenesis
Sympathetic activity Parasympathetic activity
Oxidative stress Renal function
Inflammation Sodium handling
Body weight/body mass Insulin sensitivity/glucose handling
Psychosocial stress Baroreflex sensitivity
Vascular responsive to adrenergic- 
and endothelin-receptor stimulation
Nitric oxide (NO)
individuals, drawing upon the available literature, there is evidence 
to support that exercise has antihypertensive effects and benefits 
on vascular function. In addition, it is plausible to assume that the 
role of exercise in modifying cardiovascular risk factors may pre-
vent cognitive decline and potentially reduce the risk of dementia 
in hypertensive individuals.
Although some studies have shown that PE can improve cerebro-
vascular function and cerebrovascular structure, RCTs focusing on 
hypertensive individuals are needed. Further research is needed to 
show how different modalities of physical training (AE, dynamic 
RT, isometric RT and combined exercises) and their characteristics 
(frequency, intensity, type and time) act on cerebrovascular struc-
ture and function and their implications for cognitive function in 
this population. Brain function and structure may be assessed by 
different techniques such as arterial spin marking or Functional 
Magnetic Resonance Imaging (fMRI), which provides a noninva-
sive quantitative measure of BF in specific brain regions. fMRI has 
been used as an approach to examine CBF in regions of interest 
associated with cognitive dysfunction and dementia. In addition, 
it may allow a broader understanding of the potential effect of PE 
training acting as a preventive or therapeutic strategy as well as 
preventing or restoring impaired brain perfusion and potentially 
impaired cognitive function with advancing age in hypertensive 
patients.
CONFLICTS OF INTEREST
The authors declare they have no conflicts of interest.
AUTHORS’ CONTRIBUTION
MLP, EB and PGC conceived and performed the systematic review. 
MLP, EB and PGC provided physical exercise, hypertension and 
cognitive function. MLP wrote the manuscript with input from all 
authors.
FUNDING
No funds or grants were received for the preparation of this 
manuscript.
84 M.L. Pedralli et al. / Artery Research 25(3-4) 81–86
ABBREVIATIONS
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Alzheimer’s diseases; PE, physical exercise; CBF, cerebral blood 
flow; AE, aerobic exercise; RT, resistance training; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; VO2max, maximum 
volume of oxygen; FMD, flow-mediated dilation; HR, heart rate; 
PWV, pulse wave velocity; 1RM, one-repetition maximum; CT, 
combined training; CVD, cardiovascular disease; PA, physically 
active; BDNF, brain derived neurotrophic factor; BBB, blood-brain 
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RCTs, randomized clinical trials; ASL, spin marking; fMRI, func-
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